CMMB   $1.71  1.79% Market Closed After Close 1.7033 -0.39%

Chemomab Therapeutics Ltd
Total Cash 12.73M
totalCashPerShare 0.044
EBITDA -15.97M
Total Debt 360.00K
quickRatio 3.106
currentRatio 3.123
Total Revenue
debtToEquity 3.605
Revenue/Share
ROA -0.4618
ROE -0.93802
grossProfits
freeCashflow -11.36M
operatingCashflow -16.13M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 500.26M
forwardPE -44.48
floatShares 166.64M
sharesOutstanding 14.36M
sharesShort 215.17K
sharesShortPriorMonth 78.01K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.12%
heldPercentInstitutions 0.25%
Short Ratio help_outline 0.90%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 0.695
Price To Book help_outline 2.56
earningsQuarterlyGrowth
netIncomeToCommon -15.00M
trailingEps -1.06%
forwardEps -0.04%
enterpriseToEbitda -31.33
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.01 3Q 2024
institutionsCount 17
lastUpdated Sept. 16, 2024, 8:16 p.m.